Gain Therapeutics Inc logo

GANX

NASDAQ

Gain Therapeutics Inc

Price unavailable — configure POLYGON_API_KEY

Key Statistics
Market Cap$78.60M
P/E RatioN/A
Div. Yield
EPS (TTM)-$0.61
52W High$4.34
52W Low$1.41
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees
Price Performance
1 Week+1.09%
3 Month-37.71%
1 Year+3.35%
FinancialsAnnual · QuiverQuant
Revenue$55,180
Assets$18.61M
Liabilities$6.03M
Net Income$22.27M loss

About

Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. The company is headquartered in Bethesda, Maryland.

WebullFree stocks

Advanced charting, extended hours trading, and free stock for new accounts.

Open Account
Analyze GANX with professional charts— Free to start

Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.